Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Perotti NH"'
Autor:
Showalter MR; West Coast Metabolomics Center, University of California Davis, USA., Wancewicz B; West Coast Metabolomics Center, University of California Davis, USA., Fiehn O; West Coast Metabolomics Center, University of California Davis, USA., Archard JA; Department of Otolaryngology, University of California Davis, USA., Clayton S; Department of Otolaryngology, University of California Davis, USA., Wagner J; Drug Discovery Consortium, University of California, USA., Deng P; Department of Neurology, University of California Davis, USA., Halmai J; Department of Neurology, University of California Davis, USA., Fink KD; Department of Neurology, University of California Davis, USA., Bauer G; Good Manufacturing Practice Facility, University of California Davis, USA., Fury B; Good Manufacturing Practice Facility, University of California Davis, USA., Perotti NH; Good Manufacturing Practice Facility, University of California Davis, USA., Apperson M; Department of Neurology, University of California Davis, USA., Butters J; Department of Neurology, University of California Davis, USA., Belafsky P; Department of Otolaryngology, University of California Davis, USA., Farwell G; Department of Otolaryngology, University of California Davis, USA., Kuhn M; Department of Otolaryngology, University of California Davis, USA., Nolta JA; Stem Cell Program, University of California Davis, USA., Anderson JD; Department of Otolaryngology, University of California Davis, USA. Electronic address: joanderson@ucdavis.edu.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2019 May 14; Vol. 512 (4), pp. 729-735. Date of Electronic Publication: 2019 Mar 26.
Autor:
Yuan O; 1 Department of Otolaryngology, University of California, Davis, Davis, California., Lin C; 1 Department of Otolaryngology, University of California, Davis, Davis, California., Wagner J; 2 Drug Discovery Consortium, University of California, San Francisco, San Francisco, California., Archard JA; 1 Department of Otolaryngology, University of California, Davis, Davis, California., Deng P; 3 Department of Neurology, University of California, Davis, Davis, California., Halmai J; 3 Department of Neurology, University of California, Davis, Davis, California., Bauer G; 4 Good Manufacturing Practice Facility, University of California, Davis, Davis, California., Fink KD; 3 Department of Neurology, University of California, Davis, Davis, California., Fury B; 4 Good Manufacturing Practice Facility, University of California, Davis, Davis, California., Perotti NH; 4 Good Manufacturing Practice Facility, University of California, Davis, Davis, California., Walker JE; 5 Stem Cell Program, University of California, Davis, Davis, California., Pollock K; 5 Stem Cell Program, University of California, Davis, Davis, California., Apperson M; 3 Department of Neurology, University of California, Davis, Davis, California., Butters J; 3 Department of Neurology, University of California, Davis, Davis, California., Belafsky P; 1 Department of Otolaryngology, University of California, Davis, Davis, California., Farwell DG; 1 Department of Otolaryngology, University of California, Davis, Davis, California., Kuhn M; 1 Department of Otolaryngology, University of California, Davis, Davis, California., Nolta J; 5 Stem Cell Program, University of California, Davis, Davis, California., Anderson JD; 1 Department of Otolaryngology, University of California, Davis, Davis, California.
Publikováno v:
Stem cells and development [Stem Cells Dev] 2019 Mar 15; Vol. 28 (6), pp. 398-409. Date of Electronic Publication: 2019 Feb 26.
Autor:
Lacher MD; BriaCell Therapeutics Corp., Berkeley, CA, United States., Bauer G; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Fury B; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Graeve S; BriaCell Therapeutics Corp., Berkeley, CA, United States., Fledderman EL; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Petrie TD; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Coleal-Bergum DP; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Hackett T; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Perotti NH; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Kong YY; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States., Kwok WW; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States., Wagner JP; BriaCell Therapeutics Corp., Berkeley, CA, United States., Wiseman CL; BriaCell Therapeutics Corp., Berkeley, CA, United States., Williams WV; BriaCell Therapeutics Corp., Berkeley, CA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 May 15; Vol. 9, pp. 776. Date of Electronic Publication: 2018 May 15 (Print Publication: 2018).